SOPHY
SOPHY is a Hamburg-based, privately held cloud software company founded in 2018 that provides workflow visibility, asset tracking, checklist management, and cost monitoring tools for business operations.
- Company typePrivate
- Founded2018
- HeadquartersHamburg, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What SOPHY does
SOPHY is a privately held, for-profit cloud software company headquartered in Hamburg, Germany, founded in 2018. Per the firmographic record, the company provides a cloud-based platform focused on four functional areas: workflow visibility, asset tracking, checklist management, and cost monitoring. The stated employee range of 1–10 indicates an early-stage, micro-cap SaaS operation. No further information is disclosed regarding the underlying technology stack, pricing model, go-to-market motion, distribution channels, customer segments, or geographic footprint.
The firm's public-facing website is referenced as sophy.com, but no first-party product, pricing, customer, or technical content is included in the supplied dataset. The firmographic block provides only a one-line functional description and basic firmographics, and no funding rounds, investor disclosures, leadership team entries, partnerships, awards, patents, or product launches are recorded.
A material data quality caveat applies to this analysis: the aggregated source set also contains substantial content describing SOPHYSA — a French-headquartered medical device company competing in the LP Shunt / hydrocephalus device market against Medtronic, Integra LifeSciences, and MIETHKE MedTech — together with unrelated content from a German water-filter retailer (Sanquell). The SOPHYSA and Sanquell material is treated here as a data aggregation artifact and is not used to characterize SOPHY. As a result, the investment-relevant evidence base for SOPHY is limited to the firmographic fields above, and any conclusions carry low confidence.
SOPHY firmographics
Firmographics- Name
- SOPHY
- Legal name
- SOPHYSA
- Website
- https://sophy.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SOPHY is a Hamburg-based, privately held cloud software company founded in 2018 that provides workflow visibility, asset tracking, checklist management, and cost monitoring tools for business operations.
- Ownership category
- akta.pro rank
SOPHY industry classification
Industry- Product category
- Neurosurgical implants
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Suction, Irrigation & Fluid Management Systems (HLAHADAK)
Keywords
Where SOPHY is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Markets served
SOPHY business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
SOPHY product offering
Product offeringCore offering
SOPHY (also referenced as SOPHYSA) is a medical device company specializing in hydrocephalus management solutions. Its core offering is the Lumboperitoneal (LP) Shunt System, a surgical implant designed to drain cerebrospinal fluid from the lumbar subarachnoid space to the peritoneal cavity, used in the treatment of idiopathic normal pressure hydrocephalus (iNPH). The device incorporates adjustable valve technology intended to reduce overdrainage complications.
Product overview
SOPHY (SOPHYSA) is a medical device company specializing in hydrocephalus management solutions. The company offers the Lumboperitoneal (LP) Shunt System as its core product, a surgical implant device designed to drain cerebrospinal fluid from the lumbar subarachnoid space to the peritoneal cavity. SOPHYSA competes alongside major players Medtronic, Integra LifeSciences, and MIETHKE MedTech in the global shunt systems market.
Differentiator
Problem solved
Functional benefit
Products and services
- Lumboperitoneal (LP) Shunt System Medical implant device for cerebrospinal fluid drainage used in treating idiopathic normal pressure hydrocephalus (iNPH). Features adjustable valve technology to reduce overdrainage complications. The device drains CSF from the lumbar subarachnoid space to the peritoneal cavity and is sold for use by neurosurgical hospitals and clinical providers.
Companies that use SOPHY
Customer profileIdeal customer profiles1 record
SOPHY technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SOPHY partnerships and signals
Strategic signalScale indicators3 records
Recent moves1 record
SOPHY competitors and assessment
Company assessmentEmerging players
- Penumbra: U.S.-based neurovascular and neurosurgery company with growing portfolio in adjacent neuroprocedural devices. Represents a potential adjacent or emerging competitor as it expands into neuro implants.
Broad incumbents
- DePuy Synthes (Johnson & Johnson): Johnson & Johnson's orthopedics/neurosurgery arm offering neurosurgical implants and adjacent devices. A broad incumbent operating in the neurosurgical space SOPHY targets.
- Stryker: Large diversified medical device company with a neurosurgery and spine portfolio that intersects with SOPHY's neurosurgical implant category, though not a focused hydrocephalus competitor.
- Medtronic: Global medical device leader with a CSF management portfolio (Strata, Delta) that directly competes with SOPHY's LP Shunt System. Significantly larger scale, broad neurosurgery footprint, and dominant hospital relationships.
- B. Braun: Through its Aesculap neurosurgery division, B. Braun offers hydrocephalus shunts and a broader surgical portfolio. Significantly larger player that competes in the same end-market.
- Integra LifeSciences: Through its Codman Neurosurgery line (Certas, Hakim programmable valves), Integra is a direct competitor in hydrocephalus shunts and benefits from broad neurosurgery infrastructure and scale.
Direct peers
- Spiegelberg: Hamburg-based neurosurgical device manufacturer offering shunt systems and intracranial pressure monitoring. Geographically and product-overlap comparable to SOPHY's hydrocephalus focus.
- Hpbio: Identified alongside SOPHYSA as a key player in the LP Shunt market. Specializes in neurosurgical implants including CSF shunts, making it a direct competitor in the same niche segment.
- Christoph Miethke: Germany-based specialist focused on hydrocephalus valves and shunts (proGAV, M.blue). Closest direct competitor to SOPHY in design philosophy, clinical focus, and European market overlap.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
SOPHY social profiles
Digital presenceSOPHY financial estimates
Financial estimateRevenue estimate
Valuation estimate
SOPHY leadership team
Management profileNumber of profiles
SOPHY funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SOPHY M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SOPHY
What does SOPHY do?
SOPHY (also referenced as SOPHYSA) is a medical device company specializing in hydrocephalus management solutions. Its core offering is the Lumboperitoneal (LP) Shunt System, a surgical implant designed to drain cerebrospinal fluid from the lumbar subarachnoid space to the peritoneal cavity, used in the treatment of idiopathic normal pressure hydrocephalus (iNPH). The device incorporates adjustable valve technology intended to reduce overdrainage complications.
When was SOPHY founded?
SOPHY was founded in 2018. It employs 1 to 10 people.
Where is SOPHY based?
SOPHY is headquartered in Hamburg, Germany, in the Europe region.
Who are SOPHY's main competitors?
Penumbra is listed as an emerging player. Broad incumbents are DePuy Synthes (Johnson & Johnson), Stryker, Medtronic, B. Braun and Integra LifeSciences. Direct peers are Spiegelberg, Hpbio and Christoph Miethke.
Does SOPHY have an API?
No public API is recorded for SOPHY.
What industry is SOPHY in?
SOPHY's product category is Neurosurgical implants. Its primary akta.pro industry code is HLAHADAK, Suction, Irrigation & Fluid Management Systems. Its SIC code is 3842.